HDAC9 and leukemia: Intelligent HDIs to target several ligands in the cell have been investigated as a substitute for multi-drug compounds since the therapeutic effects of single drugs can be easier predicted.4,79 Overexpression evaluation of each HDAC in leukemias can raise them as treatment targets in a strategy to treat malignancy.